COVID-19 and the Liver
AASLD created an expert panel to provide clinically useful information for hepatologists, liver transplant care providers, and their patients. The following resources are designed to provide clinicians with clinical guidance and resources to share with patients.
COVID-19 and the Liver Webinar Series
In response to the COVID-19 pandemic, AASLD has created a series of webinars dedicated to ongoing discoveries and discussions about how it affects the care of liver patients. These webinars, including those in which we collaborated with sister organizations, are located on the "COVID-19 and the Liver Webinar Series" page.
Statement on COVID-19 Vaccines and Clinical Best Practice for Hepatology and Liver Transplant Providers
These documents provide data on what is known about COVID-19 and the safe and effective use of COVID-19 vaccines for patients with liver disease. Our aim is to provide a basic template for the development of clinical recommendations and policies to mitigate the impact of the COVID-19 pandemic on liver patients and healthcare providers.
These documents are updated regularly as more data become available and additional vaccines are authorized for use.
Download the expert panel statements and documents:
Clinical Best Practice Advice for Hepatology and Liver Providers During the COVID-19 Pandemic [updated November 2, 2021]
Vaccines to Prevent COVID-19 Infection in Patients with Liver Disease [updated March 28, 2022]
Joint Society Messages
Joint Society Message: Supplemental Funding for VA Research to Support COVID-19 Research Efforts Needed
Joint Society Message: Use of Personal Protective Equipment in GI Endoscopy
Joint Society Message: Gastroenterology Professional Society Guidance on Endoscopic Procedures during the COVID-19 Pandemic
Joint GI Society Message: COVID-19 Clinical Insights for Our Community of Gastroenterologists and Gastroenterology Care Providers
Additional Resources for Clinicians
Resources for Trainees and Early Career Health Care Professionals
AASLD hosted a "Trainee and Early Career Experience in Hepatology during COVID-19" webinar. Download the Q&A document [PDF].
What You Can Do
- Submit COVID-19 Manuscripts. AASLD is seeking COVID-19 manuscript submissions. Read the letter from AASLD former journal Editors-in-Chief David Cohen, Paul Martin and Gyongyi Szab for details.
Submit to Our Journals
- Join the Conversation about COVID-19. AASLD members have an outlet to share and discuss COVID-19 and how it's affecting care delivery to patients with liver disease.
See the Latest Posts
- Report Cases to the SECURE-Liver Registry. UNC-Chapel Hill aims to assess outcomes of COVID-19 in patients with chronic liver disease and prior liver transplant including updated questions on the role of living conditions and employment, alcohol use, thromboembolic complications, novel COVID-19 therapies, emerging SARS-CoV-2 variants and post-vaccination infections. To help further their research, report cases (hyperlinked text for “report cases”) of COVID-19 in chronic liver disease and post-liver transplant patients, regardless of severity of COVID-19 (including asymptomatic patients detected through public health screening).
Submit a Case